中医综合方案治疗慢性乙型肝炎肝纤维化的效果

The Effect of Treatment of Chronic Hepatitis B hepatic Fibrosis With Comprehensive Traditional Chinese Medicine

目的慢性乙型肝炎肝纤维化患者通过中医综合方案进行治疗,评价中医综合方案的治疗效果。方法从本院在2018年3月-2019年3月间收治的慢性乙型肝炎肝纤维化患者中随机抽取200例患者,随机分组成观察组和对照组各100例,对照组患者通过益肝抗纤方法进行治疗,观察组患者通过中医综合方案进行治疗。结果观察组患者的TP、GCT、ALT水平分别为(78.6±3.8)g/L,(38.6±14.8)IU/L,(46.2±18.8)IU/L,对照组患者的TP、GCT、ALT水平分别为(76.1±3.3)g/L,(81.5±30.9)IU/L,(84.8±25.1)IU/L,组间差异有统计学意义,P<0.05;观察组患者的肝脾肿大、肝区疼痛、腹胀的患者百分比低于对照组患者,P<0.05。结论通过中医综合方案对慢性乙型肝炎纤维化患者进行治疗,患者的肝功能指标得到明显改善。

Objective Patients with chronic hepatitis B liver fibrosis are treated by a comprehensive Chinese medicine program to evaluate the therapeutic effect of the comprehensive Chinese medicine program.Methods From March 2018 to March 2019 in our hospital,200 patients with chronic hepatitis B liver fibrosis were randomly selected and randomly divided into observation group and control group,100 patients in each group.The treatment was carried out by the method of hepatitis B liver fibrosis,and the patients in the observation group were treated by a comprehensive Chinese medicine program.Results The TP,GCT,and ALT levels in the observation group were(78.6±3.8)g/L,(38.6±14.8)IU/L,(46.2±18.8)IU/L,and TP and GCT in the control group.The ALT levels were:(76.1±3.3)g/L,(81.5±30.9)IU/L,(84.8±25.1)IU/L.Differences between groups are statistically significant,P<0.05.Patients in the observation group had liver and splenomegaly,pain in the liver area,and patients with abdominal distension were less likely than patients,P<0.05.Conclusion The treatment of chronic hepatitis B fibrosis patients through the comprehensive Chinese medicine program,the patient’s liver function indicators have been significantly improved.